Objective
to determine whether oxygen supply (oxygen 6 L/min for 6-12h) in patients with PCI for STEMI reduces MACE or procedural adverse events compared to ambient air
Study
open-label multicentre randomised trial
Population
patients with suspected AMI who are normoxemic
Endpoints
composite of all-cause death, rehospitalisation with MI, cardiogenic shock or stent thrombosis at 1Â year
Conclusion
supplemental oxygen in patients with PCI for STEMI does not significantly reduce 1 year major adverse events
Hofmann et al. Eur Heart J. 2018;39:2730-39
